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Objective: This study was undertaken to define matrix metalloproteinase (MMP) expression in the anterior and posterior
wall of descending thoracic aortic aneurysms (TAAs) and correlate it with specific computed tomography (CT) image sites
within the descending thoracic aorta.
Methods: Serial CT images of patients with TAAs were compared with age- and gender-matched normal descending
thoracic aortas at levels T4-T12. The mean circumference of the TAAs was 153 mm (n  12) and 148 mm (n  11) at
T8 and T10, respectively, compared with 75 mm (n 12) and 75 mm (n  10) in controls (P < .001). Aortic tissue was
collected from a separate set of eight patients undergoing descending TAA resection (processed <12 hours of excision)
and six cadavers (processed <24 hours of death). Tissue collected between the intercostals arteries was defined as
posterior wall, and directly opposite was the anterior wall. MMP-9 andMMP-2messenger RNA (mRNA) extracted from
aortic tissue was analyzed by quantitative real time polymerase chain reaction (PCR) and normalized to -actin.
Immunohistochemistry was performed for MMP-9 and MMP-2. CT aortic measurements and MMP expression were
compared by t tests and analysis of variance, respectively.
Results: The ratio of arc distance between the intercostals on the posterior wall to total aortic circumference was 0.14 in
healthy controls compared with 0.08 in TAAs at vertebral level T8 (P  .001). At T10, the ratio was 0.15 in healthy
controls compared with 0.11 in TAAs (P  .001). MMP-9 expression in TAAs was 4.3-fold higher in the anterior wall
compared with the posterior wall (P .03). Conversely, MMP-2 expression in TAAs was 3.2-fold higher in the posterior
wall compared with the anterior wall (P  .008). MMP expression was not detected in control cadaver aortas.
Conclusion:Anterior walls of expanding TAAs grow at a greater rate than the posterior wall, as determined from the lower
ratio of intercostal arc distance to total circumference in TAAs. Differential MMP expression appears to be a biologic
marker for asymmetric growth in the TAA wall.
Clinical Relevance: The pathogenesis of thoracic aortic aneurysms (TAAs) is poorly understood. Multiple lines of
evidence suggest that matrix metalloproteinases (MMPs), a family of enzymes, are important in aneurysm development.
Earlier experiments documented a regional variation of MMP-9 in stimulated rodent aortas, with production greater in
the abdominal aorta compared with the thoracic aorta. The present study extends that observation and documents
asymmetric aneurysm development in the TAA wall, with increased anterior wall growth in correlation to increased
MMP-9 production. An improved understanding of the mechanisms by which MMP production is regulated is critical.
(J Vasc Surg 2006;43:342-8.)Aortic aneurysms account for considerable cardiovas-
cular mortality. The descending thoracic aorta accounts for
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342approximately 10% of aortic aneurysms.1 Although key
factors responsible for aortic aneurysm initiation are incom-
pletely understood, underlying events such as smooth mus-
cle cell apoptosis and cystic medial necrosis have been
identified in the pathogenesis of thoracic aortic aneurysms
(TAAs).1,2 Factors common to both abdominal and tho-
racic aortic aneurysms include elastin fragmentation,
smooth muscle cell depletion, and increased expression of
matrix metalloproteinases (MMPs).3-5
Copyright © 2006 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.10.013
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involved in the degradation of extracellular matrix, are
considered to be of central importance in the pathogenesis
of abdominal aortic aneurysms (AAAs).6-11 Notably,
MMP-9 (a 92 kD gelatinase) and MMP-2 (a 72 kD gelati-
nase) have been shown to be critical in the destructive
process that accompanies aneurysm development, as evi-
denced by inhibition of experimental AAA formation in
mice with a targeted disruption of the MMP-9 or MMP-2
gene.12 The relevance of MMPs in TAA formation is less
well known.
A recent study by Ikonomidis et al13 demonstrated that
TAA formation was increased in tissue inhibitor of matrix
metalloproteinase TIMP–/– deficient mice compared with
controls. Although MMPs and TIMPs in TAAs may be
inter-related, their involvement in TAAs is likely different
than in infrarenal AAAs. Experimentally, TAAs and infra-
renal AAAs exhibit distinct patterns of gene expression
relative to normal aorta, with many alterations being site-
specific.14 In a study by Ailawadi et al15 from our labora-
tory, expression of MMPs appeared geographically and not
intrinsically regulated within the aortic wall in rodents. It is
hypothesized that MMP-9 and MMP-2 expression is geo-
graphically dependent and may contribute to site-specific
aneurysmal dilation of TAAs in humans. The objective of
the present study was to investigate growth patterns of
TAAs in humans and to correlate such with the biochemical
environment of MMPs in the aortic wall.
METHODS
Project approval and informed consent for both obtain-
ing and reviewing computed tomography (CT) scans and
use of aortic tissue were obtained as dictated by the Uni-
versity ofMichigan Institutional Research Board guidelines
(UM IRB #2003-0497).
Assessing TAA growth pattern. All CT scans were
performed using GE LightSpeed scanners (GE Healthcare
Technologies, Waukesha, Wisc). Thoracic CT scans were
obtained in 12 patients with known TAAs (9 men, 3
women; mean age, 53.7  1.4 years) and 12 healthy
controls (9 men, 3 women; mean age, 56.7  3.1 years)
undergoing CT scans to assess pulmonary vein anatomy
before radiofrequency ablation by cardiac electrophysiol-
ogy. Age and gender were not statistically different be-
tween the groups.
Both CT groups were without evidence of significant
thrombus deposition on the walls. The circumference of
the aortic lumen and the intervening arc distance between
the midpoint of posterior intercostal arteries were deter-
mined at levels T8 and T10 by using GE Advantages
computer workstation (GE Medical System, Milwaukee,
Wisc) for Windows (Microsoft, Redmond, Wash). Radiol-
ogists participating in the study performed all measure-
ments.
The posterior wall of the aorta was defined as being
within the posterior intercostals, and the wall directly op-
posite to the intercostals was defined as the anterior wall
(Fig 1 A, and B). The ratio of intercostal arc distance tototal circumference was used as a marker for the posterior
wall’s contribution to the overall circumference. This vari-
able was used instead of absolute intercostal distance be-
cause it takes into account growth of the anterior and
posterior walls in relevance to overall circumference, which
Fig 1. A, Computed tomography (CT) scan of healthy aorta and
intercostal arteries (arrows). The segment labeled P and confined
by the arrows is defined as the posterior aortic wall. A, Anterior
aortic wall; L, lumen. B, CT scan of a thoracic aortic aneurysm and
intercostal arteries (arrows). Notice the increased length of the
anterior wall (opposite the intercostals) compared with control
aorta. There is less of an increase in length of the posterior wall. A,
Anterior aortic wall; P, posterior aortic wall; L, lumen.better defines asymmetric aortic wall expansion.
g ao
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separate group of eight patients undergoing asymptomatic
TAA resection (6 men, 2 women; mean age, 62  3.1
years), who did not exhibit other aortic pathology such as
an inherited connective tissue disorder, a congenital aortic
abnormality, or an aortic dissection. TAAs were all 5 cm
in diameter, with a maximum size of 7 cm. All patients were
Crawford type I, and all tissue isolated was from within the
thoracic cavity. Intercostal reimplantation was not per-
formed in any of the patients.
Full-thickness aortic samples were obtained at the site
of maximum dilatation from between the intercostals (pos-
terior wall) and from the opposite wall (anterior wall)
(Fig 2). Separate anterior and posterior aortic wall samples
were also obtained distal to the site of the pathologic aortic
dilation. Control cadaveric aorta was obtained from six
patients (4 men, 2 women; mean age, 57 5.4 years) with
no overt atherosclerotic disease. All cadaveric aortic speci-
mens were collected 24 hours of death before fixation.
These samples were procured at levels T8 and T10 from
between the intercostals (posterior wall) and from the
opposite wall (anterior wall). Gender and age differences
between the two groups were not statistically significant.
All aortic tissue was washed with ice-cold phosphate buff-
ered saline and immediately subjected to messenger RNA
(mRNA) extraction and immunohistochemistry.
Measurement of MMP expression. MMP-2, MMP-9,
and -actin mRNA expression was determined using real-
time polymerase chain reaction (PCR). Messenger RNA
was isolated by treatment of sample tissue with TRIzol
reagent (Invitrogen, Carlsbad, Calif) and reverse transcrip-
tion after incubating with oligo-dT primer (Life Technol-
ogies, Grand Island, NY) and M-MLV Reverse Transcrip-
tase (Life Technologies) at 94°C for 3minutes, followed by
incubation at 40°C for 70 minutes. The resulting cDNA
was amplified by Taq Polymerase (Promega, Madison,
Wisc) in the SmartCycler quantitative PCR system (Ce-
Fig 2. Thoracic aortic aneurysm specimen with a rela
significant dilatation in the anterior portion of the aorti
aortic tissue samples are taken.White arrows point to pai
taken at the interface of aneurysmal and normal-appearinpheid, Sunnyvale, Calif). SYBR intercalating dye (Roche,Indianapolis, Ind) was used to monitor complimentary
DNA (cDNA) amplification for each gene. SmartCycler
quantification data is presented as cycle threshold (Ct).
Human MMP-2, MMP-9, and -actin primer se-
quences were derived using Primer Premier software (Pre-
mier Biosoft Int, Palo Alto, Calif) based on primary cDNA
sequences from GenBank (http://www.ncbi.nlm.nih.
gov/Genbank/) as follows:
MMP-2 sense: 5=-AGATCTTCTTCTTCAAGGAC-
CGGTT-3=
MMP-2 antisense: 5=-GGCTGGTCAGTGGCTTGG-
GGTA-3=
MMP-9 sense: 5=-CTTCCCTGGAGACCTGAGAACC-3=
MMP-9 antisense: 5=-TGCCACCCGAGTGTAACA-
AT-3=
-actin sense: 5=-GAAGATGACCCAGATCATGTT-
TG-3=
-actin antisense: 5=-AGCACAGCCTGGATAGCAAC-3=
Matrix metalloproteinase results were normalized us-
ing the constitutively expressed -actin gene. Quantifica-
tion of mRNA levels used Ct values calculated from the
formula Ct  Ct target gene – Ct -actin. Expression of the
target gene in ratio to -actin expression was calculated by
the formula: target gene expression/-actin expression 
2-(Ct).
Immunohistochemistry. A representative sample was
taken from both the TAA anterior and posterior wall at the
level of maximal dilation. Tissue was fixed in 4% parafor-
maldehyde and embedded in paraffin. Hematoxylin and
eosin (H and E) staining was done to facilitate white blood
cell (WBC) counts. WBC counts were performed by an
observer blinded to anatomic origin of the samples (n  3
at each site). WBC counts were averaged from 20 high
power fields (HPFs) per sample at 100 magnification in
both media and adventitia. Cell types were identified by a
trained observer using H and E stained slides.
MMP-9 immunohistochemistry was performed by
preserved posterior wall between the intercostals and
. Black arrows point to sites from which corresponding
osterior intercostal arteries. The distal tissue samples are
rta.tively
c wall
red pdeparaffinization and rehydration using xylene and decreas-
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tivity was blocked with 3% hydrogen peroxide in methanol.
Staining was then performed with MMP-9 Ab-9 rabbit
polyclonal antibody (NeoMarkers, Inc, Fremont, Calif)
and rabbit immunoglobulin G (IgG) with Vectastain
ABC-AP Kit (Vector Laboratories, Burlingame, Calif). The
Vector Red Alkaline Phosphatase Substrate Kit was then
used, followed by Hematoxylin QS counterstain, both
from Vector Laboratories.
MMP-2 samples were stained by deparaffinization, re-
hydration, and unmasking by using Trilogy (Cell Marque
Corp, Hot Springs, Ark) in an electric pressure cooker
(Princess model, Tristar Products, Parsippany, NJ). Endog-
enous peroxidase activity was blocked with 3% hydrogen
peroxide in methanol. Staining was then performed with
MMP-2 Ab-4 mouse monoclonal antibody (NeoMarkers)
and mouse IgG Vectastain ABC-AP Kit. The Vector Red
Alkaline Phosphatase Substrate Kit was then used, followed
by Hematoxylin QS counterstain. Representative samples
were chosen subjectively as depictions of the overall noted
histology.
Data analysis. Data are reported as mean  standard
error. Thoracic and healthy control CT scans were analyzed
by using the nonpaired Student’s t test. MMP expression in
aortic tissue was compared by using analysis of variance.
Cell counts were compared by using paired t tests. Statisti-
cal significance was assigned as P  .05. All analysis was
performed with GraphPad Prism 3.0 software (GraphPad,
San Diego, Calif).
RESULTS
Anterior aortic wall dilates at a greater rate than
posterior aortic wall. Age and gender were not signifi-
cantly different between control and TAA patients by linear
and logistic regression, respectively. The mean circumfer-
ence of control, nonaneurysmal aortas was 75mm (n 12)
and 75mm (n 10) at T8 and T10, respectively, compared
with 153mm (n 12, P .001) and 148mm (n 11, P
.001) in TAAs. Themean posterior wall distance of control,
nonaneurysmal aortas was 10.1 mm (n 12) and 11.4 mm
(n  10) at T8 and T10, respectively, compared with 12.9
mm (n  12, P  .134) and 17.7 mm (n  11, P  .036)
in TAAs. CT scans of nonaneurysmal aortas from healthy
controls demonstrated a ratio of arc distance between the
intercostals to the total circumference of the aorta to be
0.14  0.01 and 0.15  0.01 at T8 and T10, respectively
(n  20). In contrast, the arc distance to circumference
ratio in TAAs was reduced significantly at T8 to 0.08 
0.01 (P  .001) and at T10 to 0.11  0.01 (P  .001)
(Fig 1, A and B, Table).
MMP expression in TAAs. Matrix metalloprotein-
ase expression in TAAs was increased compared with
control thoracic aortas. In TAAs, total MMP-9 and
MMP-2 ratios to -actin were 0.2405 and 0.3117, re-
spectively, whereas no MMP-9 (P  .021) or MMP-2 (P
 .013) expression was detectable in the aortic wall of
cadaveric controls (data not shown). Expression of the
-actin gene was present in cadaveric controls, and melt-curve analysis of -actin replicons revealed a single peak,
demonstrating a clean product.
TAA MMP-9 and MMP-2 expression. Thoracic
aortic aneurysm MMP-9 was higher in the anterior wall,
whereas MMP-2 expression was higher in the posterior
wall. MMP-9 expression was elevated in TAA anterior walls
at the level of the aneurysm (0.81  0.44) compared with
the posterior wall (0.15  0.15, P  .03) (Fig 3, A). In
contrast, MMP-2 expression was elevated in the posterior
wall (0.52 0.19) compared with the anterior wall (0.13
Table. Asymmetric growth ratios in thoracic
aortic aneurysms
Control Aneurysm
Level N Ratio N Ratio P
T8 12 0.14 12 0.08 .001
T10 10 0.15 11 0.11 .001
Fig 3. A, At the level of the aneurysm, matrix metalloprotein-
ase-9 (MMP-9) expression is 4.3-fold higher in the anterior wall
compared with the posterior wall. MMP-9 is minimally detectable
in the distal aspects of the aneurysm. *P.05. Data are reported as
mean  standard error. B, At the level of the aneurysm, MMP-2
expression is 3.2-fold higher in the posterior wall compared with
the anterior wall. MMP-2 is present in the distal aspects of the
aneurysm, although the level of expression is not significantly
different from MMP-2 expression at the level of the aneurysm.
*P  .05. Data are reported as mean  standard error..08, P .01) (Fig 3, B). No significant difference in
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aortic segments between the anterior and posterior walls.
These findings were confirmed by immunohistochemistry,
with subjectively increased MMP-9 staining in the anterior
wall (Fig 4, A and B) and increased MMP-2 staining in the
posterior wall (Fig 5, A and B).
In histology samples, there was no significant difference
in the number of total polymorphonuclear leukocytes per
HPF at100 magnification (3.4 4.1 anterior wall vs 2.3
Fig 4. Immunohistochemical staining of matrix metalloprotein-
ase 9 (MMP-9) in thoracic abdominal aneurysms (TAAs) demon-
strates increased staining in the anterior wall (A) compared with
the posterior wall (B) in a TAA. Arrows point to positive MMP-9
staining (100 magnification). L lumen; M, media. 1.9 posterior wall, P.48), lymphocytes perHPF (7.42.1 anterior wall vs 7.4  1.3 posterior wall, P .98), or
macrophages per HPF (0.6 0.2 anterior wall vs 0.4 0.2
posterior wall, P .20) at the level of the aneurysm in the
anterior wall compared with the posterior wall. Almost all
of the inflammatory cell infiltrate was localized to the
adventitia. No inflammatory cell infiltrate was identified in
cadaveric control aortic tissue.
DISCUSSION
This study was undertaken to determine if differential
expression of MMP-2 and MMP-9 existed in the anterior
and posterior wall of descending TAAs. From the results of
Fig 5. Immunohistochemical staining of matrix metalloprotein-
ase 2 (MMP-2) in thoracic abdominal aneurysms (TAAs) demon-
strates decreased staining in the anterior wall (A) compared with
the posterior wall (B) in a TAA. Arrows point to positive MMP-2
staining (100magnification). L,Lumen;M,media;A, adventitia.previous studies demonstrating that MMP expression may
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that variable MMP expression may lead to asymmetrical
aneurysm formation.When CT scans of patients with TAAs
were compared with healthy age-matched controls, we
noted that the arc distance, or the length of the curve
between the intercostals, made up a significantly smaller
proportion of the entire aortic diameter. This suggested an
asymmetry of dilatation, with most aneurysmal growth
occurring in the anterior aortic wall.
This study revealed that MMP-9 expression was signif-
icantly increased in the anterior TAA wall compared with
the posterior wall. Conversely, MMP-2 expression was
increased in the posterior wall compared with the anterior
wall. Distal to the aortic dilation, there was no significant
difference in MMP-9 or MMP-2 between the anterior and
posterior aortic walls. It is also important to note that
neither MMP-9 nor MMP-2 was detected in control sam-
ples, suggesting that MMP expression is unique to TAAs
and not present in nondiseased aortas. It is possible, how-
ever, that MMPmRNA was present in low levels in control
aortas but was not detected owing to degradation before
processing.
Interestingly, there was no significant difference in
inflammatory leukocytes between the anterior and poste-
rior TAA wall by observation, suggesting that altered
MMP-9 and MMP-2 expression may be secondary to al-
tered transcriptional regulation within smooth muscle cells
or differential expression by aortic wall leukocytes. It is
important to note that MMP-2 expression is indeed in-
creased in the posterior aortic wall, where there is less aortic
wall growth and more preserved media (ie, increased
smooth muscles cells, data not shown). It is possible that
MMP-2 precedes MMP-9 expression during wall expan-
sion similar to infrarenal AAAs.10
Although previous studies in patients with TAAs failed
to demonstrate the importance ofMMP-2, multiple studies
have demonstrated involvement of MMP-9 in TAA
growth.9,16 Currently, both enzymes are thought essential
in the pathogenesis of aneurysms in the infrarenal aorta. A
study by Pyo et al17 found lack of experimental AAA
development in MMP-9–/– mice. In addition, mice treated
with inhibitors to MMP-9 are resistant to aneurysm forma-
tion.18 Longo et al12 reported that neither MMP-9–/– nor
MMP-2–/– mice developed experimental aortic aneurysms.
The initial inciting event that leads to increased
MMP-9 and MMP-2 expression in the aortic wall remains
unknown. A recent study by Bunton et al19described in-
creased MMP-9 expression after identifiable phenotypic
changes in smooth muscle cells. In that study, aortic
smooth muscle cells from patients with Marfan’s syndrome
revealed alteration of their expression profile, including
increased MMP-9 accompanied by morphologic changes
that included the loss of fibrillin-1–mediated attachments
to surrounding smooth muscle cells. It is unknown if
mechanical alterations are the initial event in increased
MMP-mediated elastolysis or if it is due to an actual initial
increase in MMP expression.Other studies have suggested that increased oxidative
stress may be the initiating event in aneurysm develop-
ment.20-22Although not addressed in the present study,
candidates genes include those involved with the formation
of reactive oxygen species, which have been shown to be
increased during TAA formation.14,23 Absi et al14 specifi-
cally identified increased inducible nitric oxide synthase
expression in TAAs. Ejiri et al23 also described elevated
nicotinamide adenine dinucleotide/nicotinamide adenine
dinucleotide phosphate (NADH/NADPH) oxidase in
TAAs and speculated increased local reactive oxygen spe-
cies were associated with increased macrophage MMP pro-
duction.
Similarly, Castier et al24 described shear stress as an
etiology of increased MMP production via reactive oxygen
species formation in vascular remodeling. Differential shear
stress in the anterior and posterior TAA wall may therefore
contribute to the difference in MMP expression observed.
Limitations of the present study include the observa-
tion that the TAAs examined are all end stage (5 cm) and
that MMPs expressed at this time may differ from those
expressed during the initiation of aneurysm growth. In
addition, an increased sample size would be required to
reduce the chances of -error, as we documented nonsig-
nificant differences in MMP expression at the site of maxi-
mal dilation vs distal aortic segments. An increased sample
number would also be needed to confirm that MMP ex-
pression increases in the aortic wall in relationship to aneu-
rysm growth rate or size.
In AAAs, one study found MMP-9 expression was
highest in abdominal aortas between 4 cm and 7 cm,
suggesting a temporal or mechanical relationship with aor-
tic dilatation.25 Whether the same type of regulation occurs
in TAA growth is unknown and beyond the scope of this
study. Furthermore, no circumference data are available on
patients from which TAA tissue was isolated. The hypoth-
esis that tethering of the posterior aortic wall, via intercostal
arteries, creates an asymmetric mechanical force limiting
posterior aortic wall expansion was not investigated. Poste-
rior wall preservation may also be secondary to potentially
increased blood flow owing to its closeness to the intercos-
tals arteries.
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